Terminal patients would still need care, but in more expensive settings; other states reject similar proposals The State of Florida’s proposed elimination of the Medicaid benefit that provides hospice care to some of the state’s most fragile individuals actually would cost Florida millions more than the state currently spends – adding to the state’s budget [ Read More ]
Archive for December, 2008
The Children’s Hospital of Philadelphia is named the nation’s best pediatric hospital by Parents magazine. “Children’s Hospital employees work tirelessly everyday to ensure every family has the ideal patient experience and we are truly grateful to our dedicated and talented staff,” said Steven M. Altschuler, M.D., president and chief executive officer of The Children’s Hospital [ Read More ]
NovaRx Corporation announced the opening of the company’s pivotal Phase 3 clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC) in Serbia. Serbian oncology centers participating in the trial include the Clinical Hospital Center Benzanijska Kosa in Belgrade, the Clinic for Pulmonary Diseases and TB “Knez Selo” in Nis, [ Read More ]
According to the latest science, resveratrol pill users are best advised to consume modest doses of resveratrol plus an array of antioxidant molecules as typically provided in 3 to 5 glasses of aged, red wine, rather than resveratrol alone. The most recent study shows mega-dose resveratrol alone fails to prolong the life of laboratory mice. [ Read More ]
The American Nurses Association (ANA) is pleased to announce, on behalf of the larger nursing community, the release of a first of its kind study quantifying the economic value of nursing. The study was conducted by the Lewin Group, supported by grants from Nursing’s Agenda for the Future, the ANA and a coalition of nursing [ Read More ]
New Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist Demonstrates Rapid, Long-term Suppression of Testosterone – a hormone that stimulates prostate cancer growth. Ferring Pharmaceuticals, USA today received approval from the U.S. Food and Drug Administration (FDA) for degarelix, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist, indicated for patients with advanced prostate cancer. Potential trade names are [ Read More ]